€10.96
1.62% yesterday
Madrid, Jun 13, 05:35 pm CET
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Almirall Stock price

€10.96
+0.54 5.18% 1M
+2.62 31.41% 6M
+2.73 33.09% YTD
+1.13 11.50% 1Y
-0.94 7.90% 5Y
-6.11 35.80% 10Y
-3.31 23.21% 20Y
Madrid, Closing price Fri, Jun 13 2025
-0.18 1.62%
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Key metrics

Market capitalization €2.35b
Enterprise Value €2.38b
P/E (TTM) P/E ratio 222.80
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.63
P/S ratio (TTM) P/S ratio 1.61
P/B ratio (TTM) P/B ratio 1.60
Dividend yield 1.65%
Last dividend (FY25) €0.18
Revenue growth (TTM) Revenue growth 9.63%
Revenue (TTM) Revenue €1.46b
EBIT (operating result TTM) EBIT €70.71m
Free Cash Flow (TTM) Free Cash Flow €-660.00k
Cash position €377.30m
EPS (TTM) EPS €0.05
P/E forward 46.61
P/S forward 2.13
EV/Sales forward 2.16
Show more

Is Almirall a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Almirall Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Almirall forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Almirall forecast:

Buy
91%
Hold
9%

Financial data from Almirall

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,464 1,464
10% 10%
100%
- Direct Costs 391 391
6% 6%
27%
1,072 1,072
11% 11%
73%
- Selling and Administrative Expenses 458 458
13% 13%
31%
- Research and Development Expense 139 139
19% 19%
9%
269 269
10% 10%
18%
- Depreciation and Amortization 198 198
11% 11%
14%
EBIT (Operating Income) EBIT 71 71
6% 6%
5%
Net Profit 9.35 9.35
132% 132%
1%

In millions EUR.

Don't miss a Thing! We will send you all news about Almirall directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Carlos Piqué
Employees 2,026
Founded 1995
Website www.almirall.es

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today